Skip to main content
. 2023 Feb 14;161:105399. doi: 10.1016/j.jcv.2023.105399

Table 1.

Demographic, clinical and laboratory parameters of RSV compared to Influenza A, Influenza B and SARS-CoV-2.

Parameter / virus (n) RSV (318) Influenza A (591) Influenza B (289) SARS-Cov-2 (342) p
Demographic data
Age years 75.1 (14.3)& 72.9 (15.3)&& 75.7 (13.7)&& 70.8 (15.9)&&& < 0.001
Gender f/m 135/183 261/330 135 / 154 168 / 174 0.301
Clinical symptoms
Cough% 71& 68 66 51&& < 0.001
Headache% 7*,** 13 18 14 < 0.001
Weakness% 67#,## 67###,#### 83 78 < 0.001
Enteritis 10$ 21 20 17 < 0.001
Laboratory parameters
Body temperture °C 37.31 (0.97)& 37.54 (1.03)&&,&&& 37.27 (0.86) 37.31 (0.93) < 0.001
Leukcocytes n/ul 10.1 (7.6)*,** 8.4 (5.8) 7.4 (6.7) 8.5 (11.7) < 0.001
C-reactive protein mg/dL 62.6 (77.1)# 65.9 (81.0) 48.8 (68.8)## 83.4 (83.1)### < 0.001
Lactate dehyrogenase IU/mL 265 (114)% 309 (474) 273 (176) 409 (632)%% < 0.001
Glucose mg/dL 145 (64)$ 137 (57) 135 (69) 129 (53) 0.03

(): standard deviation.

Demographic data:.

& RSV vs. SARS: p = 0.01 (&&Influenza B vs. Influenza A: p = 0.048 / &&&SARS—CoV-2 vs. Influenza A / B: p = 0.001, respectively).

Clinical Symptoms:.

&RSV vs. SARS-CoV-2: p < 0.001 (&&SARS-CoV-2 vs. Influenza A / B: p < 0.001, respectively).

*RSV vs. Influenza B: 0.04; **RSV vs. SARS-CoV-2 < 0.001.

#RSV vs. Influenza B: p < 0.001, ##RSV vs. SARS-CoV-2: p = 0.005 (###Influemza A vs. Influenza B: p < 0.001; ####Influenza A vs. SARS-CoV-2: p = 0.001).

$RSV vs. Influenza A: < 0.001.

Laboratory parameters.

&RSV vs. Influenza A: p = 0.014 (&&Influenza A vs. Influenza B: p = 0.014 / &&&Influenza A vs. SARS-CoV-2: p = 0.010.

*RSV vs. Influenza A: p = 0.015 / ⁎⁎RSV vs. Influenza B: p < 0.001.

#RSV vs. SARS-CoV-2: p < 0.01 (##Influenza B vs. Influenza A: p = 0.016 / ###SARS-CoV-2 vs. Influenza A / B: p < 0.01, respectively).

%RSV vs. SARS-CoV-2: p < 0.01 (%%SARS vs. Influenza A / B: p < 0.01, respectively).

§RSV vs. SARS-CoV-2: p = 0.020.